Merck’s Covid pill could transform treatment. Here’s how it works

Earlier this month, research outcomes confirmed that molnupiravir, Merck’s investigational antiviral capsule, reduce hospitalization charges of Covid-19 sufferers by about half. Molnupiravir is the primary oral remedy that has proven promise in treating Covid-19. One other antiviral, remdesivir, can solely be administered intravenously.

“Having an oral choice might be a giant change,” stated Benjamin Gewurz, affiliate director of the Ph.D. program in virology at Harvard Medical College. “Some folks may simply take a capsule somewhat than having an IV or injection of some type. And that’s what could be an enormous, enormous advance.”

This video explains precisely how this drug works within the physique to fight the coronavirus.